0001104659-23-096618.txt : 20230829
0001104659-23-096618.hdr.sgml : 20230829
20230829185415
ACCESSION NUMBER: 0001104659-23-096618
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230828
FILED AS OF DATE: 20230829
DATE AS OF CHANGE: 20230829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liawatidewi Yakob
CENTRAL INDEX KEY: 0001743927
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 231223436
MAIL ADDRESS:
STREET 1: C/O AMPHASTAR PHARMACEUTICALS INC
STREET 2: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001297184
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330702205
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
BUSINESS PHONE: 909-980-9484
MAIL ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
4
1
tm2325070-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-08-28
0
0001297184
Amphastar Pharmaceuticals, Inc.
AMPH
0001743927
Liawatidewi Yakob
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
1
1
0
0
EVP Corp Admin Center
0
Common Stock
2023-08-28
4
M
0
3319
16.96
A
72988
D
Common Stock
2023-08-28
4
M
0
5497
20.23
A
78485
D
Common Stock
2023-08-28
4
M
0
20000
13.03
A
98485
D
Common Stock
2023-08-28
4
S
0
28816
53.13
D
69669
D
Common Stock
2459
I
See footnote
Employee Stock Option (right to buy)
16.96
2023-08-28
4
M
0
3319
0
D
2028-06-14
Common Stock
3319
0
D
Employee Stock Option (right to buy)
20.23
2023-08-28
4
M
0
5497
0
D
2029-03-15
Common Stock
5497
0
D
Employee Stock Option (right to buy)
13.03
2023-08-28
4
M
0
20000
0
D
2030-03-16
Common Stock
20000
16176
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.87 to $53.74, inclusive.The reporting person
undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares sold at each separate price.
The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
Shares subject to the option are fully vested and immediately exercisable.
Shares subject to the option vest in four equal annual installments beginning on March 16, 2021.
/s/ Eva Wen, by power of attorney
2023-08-29